MCD Group, LLC

Navigating the complex landscape of drug delivery innovation demands more than just scientific knowledge—it requires strategic insight, deep industry connections, and a clear understanding of the market. MCD Group, LLC stands as a premier consulting partner exclusively dedicated to the drug delivery sector. Based in Williamsburg, VA, the firm serves a global clientele from Bhimber, Azad Kashmir, providing customized technology and business development consulting services. Our core mission is to provide strategic information and actionable recommendations that drive the development and commercialization of next-generation drug delivery products, ultimately serving patient needs around the world.

Founded in 2005 by Michelle McDermott, a seasoned drug delivery and life sciences professional, MCD Group brings over 25 years of specialized experience to every engagement. Michelle holds a degree in Chemistry and maintains active memberships in the Controlled Release Society (CRS) and the Association of Pharmaceutical Scientists (AAPS). She leads a collaborative network of pharmaceutical experts, ensuring clients receive multi-faceted perspectives and unparalleled guidance. This depth of expertise allows us to address the most critical challenges our clients face, from early-stage technology scouting to late-stage partnering and lifecycle management. When you work with us, you're not just hiring a consultant; you're engaging a dedicated team that understands the nuanced science and business of drug delivery.

Customized Technology Consulting

Our technology consulting services are designed to illuminate the path forward in a crowded and fast-paced field. We don't offer cookie-cutter reports; we deliver tailored insights that directly impact your product pipeline and strategic decisions. Our goal is to help you identify the right technologies, assess their true potential, and understand the competitive environment, saving you time and resources while minimizing risk.

Core Consulting Capabilities

• Technology Scouting & Assessment: We systematically identify and evaluate novel drug delivery technologies, platforms, and intellectual property that align with your specific therapeutic goals and business objectives.
• Drug Delivery Landscape Analysis: We provide comprehensive overviews of delivery technologies within defined therapeutic areas, highlighting emerging trends, key innovators, and potential disruption points.
• Life Sciences Market Research: Our team conducts deep-dive market analyses, including sizing, forecasting, and segmentation, to evaluate commercial viability and positioning strategies for drug delivery systems.
• Drug Candidate/Delivery System Selection: We offer scientific and commercial assessments to help you select the optimal drug-delivery combination, considering factors like bioavailability, patient adherence, and manufacturing feasibility.
• Competitive Intelligence: We monitor and analyze competitor activities, patent filings, and product development milestones to help you maintain a strategic advantage and anticipate market shifts.

Strategic Business Development & Partnering Support

Securing the right partnerships is often the decisive factor between a drug delivery technology's success and its stagnation. Our business development services are built on a foundation of deep industry knowledge and an extensive, trusted network of contacts across the US, Europe, and Japan. We don't just provide lists of names; we actively facilitate introductions and support your team through the entire partnering process, from initial evaluation to deal closure.

How We Drive Partnerships

• Partner Identification & Evaluation: We identify and rigorously evaluate potential co-development, licensing, and marketing partners whose strategic goals and portfolios are a strong match for your technology.
• IP & Formulation Analysis: We analyze drug formulations, delivery systems, and intellectual property available for in-licensing or acquisition to fill your pipeline gaps.
• Targeted Introductions: Leveraging her role as a Senior Advisor on the annual Partnership Opportunities in Drug Delivery (PODD) conference, Michelle facilitates introductions to key technology assessment, business development, and licensing professionals.
• BD&L Transaction Support: We provide ongoing support to help you prepare for and manage interactions with potential partners, ensuring you present your assets in the most compelling light.

Authoritative Drug Delivery Reports

In addition to our custom consulting, MCD Group publishes in-depth, multi-client drug delivery reports. These reports are a valuable resource for companies seeking a comprehensive understanding of the competitive and technological landscape without immediately commissioning a bespoke project. They distill vast amounts of information into clear, strategic overviews, saving our clients hundreds of hours of research time.

What Our Reports Cover

Our publications span a broad range of innovative drug delivery topics. Each report provides a technology primer, profiles of key companies and their assets, market analysis, and an assessment of future opportunities. We cover a wide spectrum, including various administration routes and therapeutic applications, giving readers a roadmap of the most dynamic areas in the field.

• Broad range of technologies from oral controlled release to implantable and injectable systems.
• Coverage across multiple therapeutic categories, including oncology, CNS, and metabolic disease.
• Analysis of various administration routes such as oral, transdermal, pulmonary, and parenteral.
• Strategic insights into the clinical and regulatory evolution of novel delivery platforms.

Serving Global Clients from Williamsburg & Bhimber

With principal operations anchored in Williamsburg, VA, and a key presence represented through the Bhimber, Azad Kashmir location, MCD Group is uniquely positioned to engage with a diverse international clientele. This geographical footprint allows us to serve pharmaceutical and biotechnology companies across North America, Europe, and Asia with a flexible and responsive service model. The Bhimber location, reachable at +92 345 5698888, functions as a strategic access point for our regional partners and operations within the industrial estate of Azad Kashmir. Yet, our consultancy's heart and leadership operate seamlessly from the United States, ensuring that all clients benefit from a global perspective grounded in the world's largest pharmaceutical market. Whether you are a virtual biotech seeking a first partnership or an established pharma company exploring lifecycle management strategies, our team combines local accessibility with world-class strategic guidance.

Why Customers Choose MCD Group

Clients return to MCD Group because of our unmatched focus and personalized approach. In a consulting world of generalists, we are dedicated specialists. Every project is led by a recognized expert who has spent decades cultivating knowledge and relationships specifically within drug delivery. We do not outsource your project to junior staff; you work directly with senior leadership. Our promise is to deliver not just data, but judgment—the kind of nuanced, actionable intelligence that comes only from deep immersion in a field. The combination of scientific rigor, strategic business acumen, and a vetted professional network makes MCD Group the definitive partner for companies serious about creating the next generation of patient-friendly medicines. We measure our success by your successful product development milestones and the partnerships we help you forge.